Smith+Nephew INTELLIO Tablet
K-Number: K221929 · 2022-09-06
Device Summary
Frequently Asked Questions
What is the Smith+Nephew INTELLIO Tablet?
Smith+Nephew INTELLIO Tablet is a medical device that received FDA 510(k) clearance on 2022-09-06. The listed applicant is Smith+Nephew. The 510(k) number is K221929.
When did Smith+Nephew INTELLIO Tablet receive FDA 510(k) clearance?
Smith+Nephew INTELLIO Tablet received FDA 510(k) clearance on 2022-09-06, under 510(k) number K221929.
Who is the listed applicant for Smith+Nephew INTELLIO Tablet?
The FDA 510(k) record lists Smith+Nephew as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Smith+Nephew INTELLIO Tablet?
The FDA product code for Smith+Nephew INTELLIO Tablet is ODA.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Smith+Nephew as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: ODA)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.